93 related articles for article (PubMed ID: 27989951)
21. Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice.
Fijten GH; Starmans R; Muris JW; Schouten HJ; Blijham GH; Knottnerus JA
Fam Pract; 1995 Sep; 12(3):279-86. PubMed ID: 8536830
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic performance of scoring systems to identify symptomatic colorectal cancer compared to current referral guidance.
Marshall T; Lancashire R; Sharp D; Peters TJ; Cheng KK; Hamilton W
Gut; 2011 Sep; 60(9):1242-8. PubMed ID: 21357592
[TBL] [Abstract][Full Text] [Related]
23. Potential for Reducing Time to Referral for Colorectal Cancer Patients in Primary Care.
van Erp NF; Helsper CW; Olyhoek SM; Janssen RRT; Winsveen A; Peeters PHM; de Wit NJ
Ann Fam Med; 2019 Sep; 17(5):419-427. PubMed ID: 31501203
[TBL] [Abstract][Full Text] [Related]
24. Pitfalls in the construction of cancer guidelines demonstrated by the analyses of colorectal referrals.
Hodder RJ; Ballal M; Selvachandran SN; Cade D
Ann R Coll Surg Engl; 2005 Nov; 87(6):419-26. PubMed ID: 16263008
[TBL] [Abstract][Full Text] [Related]
25. Gastroenterologists utilize the referral for EGD to enhance colon cancer screening more effectively than primary care physicians.
Menees SB; Scheiman J; Carlos R; Mulder A; Fendrick AM
Aliment Pharmacol Ther; 2006 Apr; 23(7):953-62. PubMed ID: 16573798
[TBL] [Abstract][Full Text] [Related]
26. Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting.
Chen H; Zucknick M; Werner S; Knebel P; Brenner H
Clin Cancer Res; 2015 Jul; 21(14):3318-26. PubMed ID: 26015516
[TBL] [Abstract][Full Text] [Related]
27. Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Evidence-Based Analysis.
Health Quality Ontario
Ont Health Technol Assess Ser; 2015; 15(14):1-39. PubMed ID: 26366239
[TBL] [Abstract][Full Text] [Related]
28. Predicting colorectal cancer risk in patients with rectal bleeding.
Robertson R; Campbell C; Weller DP; Elton R; Mant D; Primrose J; Nugent K; Macleod U; Sharma R
Br J Gen Pract; 2006 Oct; 56(531):763-7. PubMed ID: 17007706
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care.
Bruins Slot MH; Rutten FH; van der Heijden GJ; Doevendans PA; Mast EG; Bredero AC; van der Spoel OP; Glatz JF; Hoes AW
Int J Cardiol; 2013 Sep; 168(2):1485-9. PubMed ID: 23332896
[TBL] [Abstract][Full Text] [Related]
30. Validation of two prognostic models predicting outcome at two years after diagnosis in a new cohort of children with epilepsy: the Dutch Study of Epilepsy in Childhood.
Geerts AT; Arts WF; Brouwer OF; Peters AC; Peeters EA; Stroink H; van Donselaar CA
Epilepsia; 2006 Jun; 47(6):960-5. PubMed ID: 16822242
[TBL] [Abstract][Full Text] [Related]
31. Referral proformas improve compliance to national colorectal 2-week wait targets: does this affect cancer detection rates?
Jani A; Jenner L; Ma F; Dutton S; Stevens R; Sharma RA;
Colorectal Dis; 2012 Nov; 14(11):1351-6. PubMed ID: 22360704
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
33. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
34. Low-dose aspirin use and performance of immunochemical fecal occult blood tests.
Brenner H; Tao S; Haug U
JAMA; 2010 Dec; 304(22):2513-20. PubMed ID: 21139112
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review.
Astin M; Griffin T; Neal RD; Rose P; Hamilton W
Br J Gen Pract; 2011 May; 61(586):e231-43. PubMed ID: 21619747
[TBL] [Abstract][Full Text] [Related]
36. The diagnostic value of digital rectal examination in primary care for palpable rectal tumour.
Ang CW; Dawson R; Hall C; Farmer M
Colorectal Dis; 2008 Oct; 10(8):789-92. PubMed ID: 17868406
[TBL] [Abstract][Full Text] [Related]
37. Exfoliated colonocyte DNA levels and clinical features in the diagnosis of colorectal cancer: a cohort study in patients referred for investigation.
Mahadavan L; Loktionov A; Daniels IR; Shore A; Cotter D; Llewelyn AH; Hamilton W
Colorectal Dis; 2012 Mar; 14(3):306-13. PubMed ID: 21689307
[TBL] [Abstract][Full Text] [Related]
38. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
[TBL] [Abstract][Full Text] [Related]
39. Comparing diagnostic delay in cancer: a cross-sectional study in three European countries with primary care-led health care systems.
Murchie P; Campbell NC; Delaney EK; Dinant GJ; Hannaford PC; Johansson L; Lee AJ; Rollano P; Spigt M
Fam Pract; 2012 Feb; 29(1):69-78. PubMed ID: 21828375
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
